An Open-Label, Dose-Escalation Study to Assess the Safety and Efficacy of IL-22 Agonist F-652 in Patients With Alcohol-associated Hepatitis.
Arab JP, Sehrawat TS, Simonetto DA, Verma VK, Feng D, Tang T, Dreyer K, Yan X, Daley WL, Sanyal A, Chalasani N, Radaeva S, Yang L, Vargas H, Ibacache M, Gao B, Gores GJ, Malhi H, Kamath PS, Shah VH.
Arab JP, et al. Among authors: yan x.
Hepatology. 2020 Aug;72(2):441-453. doi: 10.1002/hep.31046. Epub 2020 Apr 27.
Hepatology. 2020.
PMID: 31774566
Free PMC article.
Clinical Trial.